Genomics company Color gains unicorn status

Color, a Burlingame, Calif.-based population genomics and healthcare technology company, achieved unicorn status Jan. 4 when it closed a $167 million series D funding round.

Advertisement

General Catalyst and T. Rowe Price led the funding round, with significant contributions from Viking Global Investors. 

The funding round brought Color’s total financing to $278 million. It also created a valuation of $1.5 billion, which earned the seven-year-old company unicorn status.

Color plans to use the funding to strengthen its work establishing public health infrastructure and technology for governments, employers and other organizations that serve large populations.

“The opportunity to design the future of public health through technology cannot be overstated,” General Catalyst Managing Director Hemant Taneja said in a news release. “Color understands that often, challenges in healthcare aren’t scientific or medical in nature, but rather due to access barriers.” 

More articles on digital transformation:
How CIOs are building on COVID-19 digital transformation efforts in 2021
5 recent health IT, innovation partnerships
Why CIOs are gaining more influence in front-office decision making in 2021

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Digital Health

Advertisement

Comments are closed.